Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo

NCT01243450 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

958

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne

Interventions

DRUG: Tretinoin
DRUG: placebo

Sponsor

Spear Pharmaceuticals